A comparative study of the relative bioavailability of different interferon beta preparations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1998 • 2,049 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 2,032 citations

Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

1993 • 1,908 citations

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1995 • 761 citations

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b

1996 • 361 citations

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis

1998 • 332 citations

Evidence of interferon β-1a dose response in relapsing-remitting MS

1999 • 201 citations

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

1999 • 194 citations

The human intracellular Mx‐homologous protein is specifically induced by type I interferons

1990 • 161 citations

Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β‐1b

1997 • 155 citations

Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging

1995 • 150 citations

A Novel Bioassay for the Determination of Neutralizing Antibodies to IFNβ1b

1998 • 100 citations

Comparative Study of the Pharmacodynamic and Pharmacologic Effects of Betaseron^®and AVONEX^™

1998 • 92 citations

Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin.

1993 • 87 citations

Neutralizing antibodies to interferon β-1a and interferon β-1b in MS patients are cross-reactive

1998 • 74 citations

Pharmacokinetics and Pharmacodynamics of Interferon Beta-1a (IFN??-1a) in Healthy Volunteers after Intravenous, Subcutaneous or Intramuscular Administration

1997 • 54 citations

Apnoeic attacks as an isolated manifestation of epileptic seizures in infants

1998 • 26 citations

THE EFFECT OF INTERFERON β-1b ON CYTOKINE-INDUCED ADHESION MOLECULE EXPRESSION

1997 • 25 citations

[Comparison of pharmacokinetic and pharmacodynamic data of interferon-beta 1a preparations after intramuscular and subcutaneous administration].

1998 • 2 citations